Manhattan Associates Insider Sold Shares Worth $754,504, According to a Recent SEC Filing-March 2024-www.financetom.com

Manhattan Associates Insider Sold Shares Worth $754,504, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Manhattan Associates Insider Sold Shares Worth $754,504, According to a Recent SEC Filing

Nov 9, 2024 1:29 PM

04:09 PM EST, 11/08/2024 (MT Newswires) -- Edmond Eger, Director, on November 06, 2024, sold 2,675 shares in Manhattan Associates ( MANH ) for $754,504. Following the Form 4 filing with the SEC, Eger has control over a total of 10,864 shares of the company, with 10,864 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1056696/000122520824009811/xslF345X05/doc4.xml

Previous page： Clearwater Analytics Holdings Insider Sold Shares Worth $457,064, According to a Recent SEC Filing Next page： Kairos Pharma Closes $6.2 Million IPO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Clearwater Analytics Holdings Insider Sold Shares Worth $457,064, According to a Recent SEC Filing

Sep 20, 2024

04:54 PM EDT, 09/17/2024 (MT Newswires) -- James S Cox, Chief Financial Officer, on September 16, 2024, sold 18,700 shares in Clearwater Analytics Holdings ( CWAN ) for $457,064. Following the Form 4 filing with the SEC, Cox has control over a total of 227,503 shares of the company, with 227,503 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1866368/000156218024006846/xslF345X05/primarydocument.xml Price: 24.70, Change:...

Kairos Pharma Closes $6.2 Million IPO

Sep 20, 2024

04:46 PM EDT, 09/17/2024 (MT Newswires) -- Kairos Pharma ( KAPA ) said Tuesday it closed its initial public offering of 1.55 million shares at $4 each, raising $6.2 million to fund its early-stage trial in lung cancer and mid-stage trial in prostate cancer for its lead product candidate ENV 105. Kairos shares debuted on the NYSE American on Monday....

Axon Enterprise Insider Sold Shares Worth $380,990, According to a Recent SEC Filing

Sep 20, 2024

05:03 PM EDT, 09/17/2024 (MT Newswires) -- Michael Garnreiter, Director, on September 16, 2024, sold 1,000 shares in Axon Enterprise ( AXON ) for $380,990. Following the Form 4 filing with the SEC, Garnreiter has control over a total of 27,259 shares of the company, with 27,259 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1069183/000141588924023529/xslF345X05/form4-09172024_080932.xml Price: 382.89, Change: +0.32, Percent Change: +0.08...

BRIEF-Blank Check Company Roman DBDR Acquisition Corp. II Files For IPO Of Up To $200 Mln - SEC Filing

Sep 20, 2024

Sept 17 (Reuters) - Roman DBDR Acquisition Corp. II: * BLANK CHECK COMPANY ROMAN DBDR ACQUISITION CORP. II FILES FOR IPO OF UP TO $200 MILLION - SEC FILING * ROMAN DBDR ACQUISITION CORP SAYS INTEND TO APPLY TO HAVE OUR UNITS LISTED ON NASDAQ UNDER SYMBOL DRDBU, - SEC FILING * ROMAN DBDR ACQUISITION CORP. II SAYS B. RILEY...